ITGB3 p.Pro433=
c.1299C>T · rs200857868 · VCV323866
ClinGen expert panel — Platelet Disorders VCEP
Likely Benign for Glanzmann thrombasthenia. Applied ACMG criteria (verbatim):
BS1 BP7 BP4
Curation rationale (ClinGen, verbatim)
The NM_000212.2(ITGB3):c.1299C>T (p.Pro433=) synonymous variant was observed by Illumina as part of a predisposition screen in an ostensibly healthy population and has been reported in the literature in a healthy cohort (PMID: 27965976) but has not been reported in a Glanzmann thrombasthenia patient. In gnomAD v4.0.0 the minor allele frequency is 0.001910 (174/91086 alleles) in the South Asian population, which meets the BS1 threshold (>0.00158). Splicing prediction algorithms (MaxEntScan, HSF, and SpliceAI) predict no impact on splicing (BP4) and the nucleotide is not highly conserved (phyloP score 0.129449; BP7). In summary this variant meets criteria to be classified as likely benign. GT-specific criteria applied: BS1, BP4 and BP7.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -0.81 | GERP -2.9, phastCons 0.002 |
| Overall | ||
| CADD | 6.796 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.297% | 337 |
| South Asian | 0.191% | 523 |
| Admixed American | 0.108% | 923 |
| Remaining individualsnot grpmax-eligible | 0.0768% | 1,302 |
| European (non-Finnish) | 0.0371% | 2,694 |
| Ashkenazi Jewishnot grpmax-eligible | 0.0169% | 5,922 |
| African / African-American | 0.012% | 8,338 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ITGB3
- Protein
- p.Pro433=
- Coding
- c.1299C>T
- MANE Select
- NM_000212
- dbSNP
- rs200857868
- Type
- single nucleotide variant
- Location
- chr17:47292177 (GRCh38)
- Gene constraint
- LOEUF 0.685 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
- Structure
- AlphaFold pLDDT 87.19 · 125 PDB
- Residue 433
- a UniProt-annotated variant site (risk factor for fmait1; alloantigen mo(+))
Disease context
Glanzmann thrombasthenia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Glanzmann thrombasthenia (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- ITGB3 p.Pro433Ala Uncertain significance ★★ ⚠ same residue
- ITGB3 c.166-2A>G Pathogenic ★★★ same condition
- ITGB3 c.1913+1G>A Pathogenic ★★★ same condition
- ITGB3 c.1913+5G>T Likely pathogenic ★★★ same condition
- ITGB3 c.2014+1G>A Pathogenic ★★★ same condition
- ITGB3 c.2014+5G>A Likely pathogenic ★★★ same condition
- ITGB3 c.2301+1G>C Pathogenic ★★★ same condition
- ITGB3 c.361+1G>A Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/itgb3-p-pro433 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown